They require long-term use to maintain results, and stopping these medications too soon can lead to weight gain or issues with blood sugar control
The most defensible summary is that tirzepatide is the evidence-complete option available today, and retatrutide is the higher-ceiling candidate whose full value and full risk profile will only be known when its phase 3 program is published, scrutinized, and, if warranted, translated into an approval and a label
The percentage of participants achieving clinically meaningful thresholds (5%, 10%, 15%, 20%+ weight loss) exceeded anything previously seen with GLP-1 based therapies
These prescriptions are custom-prepared by licensed U.S
Mechanism: Unknown, possibly glucagon effects on peripheral nerves or rapid weight loss 3
Unable to fit into the standard sizes, her mother lovingly deconstructed a womens uniform and sewed it back together to fit her